ABITEC Corporation and DKSH Announce Expansion of Lipid Distribution Agreement
17 September 2021
ABITEC Corporation and DKSH Announce Expansion of Lipid Distribution Agreement
US ingredients supplier ABITEC Corporation signs amended agreement with DKSH to distribute their specialty lipids into new markets and regions across Europe.
ABITEC Corporation, a global manufacturer of specialty lipids, has expanded their multi-year agreement with distribution partner DKSH to include the Food and Beverage market sectors with an extended focus on nutritional supplements across more than 15 countries in the European region. DKSH, a globally acting partner who offers marketing and development to manufacturers of raw materials up to finished products will continue to exclusively distribute ABITEC’s lipid-based excipients and nutritional supplements in Thailand, Spain and Portugal, while now extending their representation into new markets and regions. The agreement strengthens an already existing relationship between the two companies and aims to help grow and expand their presence in these emerging markets. DKSH will expand their marketing of ABITEC products for Food, Beverage, and Nutritional Supplements to Denmark, Sweden, Norway, Iceland, Finland, Estonia, Latvia, Lithuania, The United Kingdom, Ireland, The Netherlands, Belgium, Luxemburg, France, Germany, Austria and Switzerland.
Damon Dalrymple, Managing Director Europe and Asia, ABITEC, states: "ABITEC's relationship with DKSH has continued to evolve over the years, and since formalizing our partnership in 2018 it has been a successful collaboration in the pharmaceutical space and in nutritional supplements. This positive experience and results have only further justified our strategic approach to continue our growth in new emerging markets. DKSH has extensive knowledge and insight into these chosen markets and possesses a top-notch logistic infrastructure that will allow ABITEC a strategic advantage in delivering ingredient solutions globally. Together, ABITEC and DKSH will have the opportunity to continue to expand their presence in new markets and serve their customers with high-quality products and technical expertise.”
Cesar Saez, Vice President, Global Food & Beverage Ingredients, Performance Materials, DKSH, added: “We are very pleased to build on our successful partnership with ABITEC by introducing their leading specialty lipids to our broad customer base of manufacturing companies in Europe.”
ABITEC’s trademarked specialty lipids include Capmul, Captex, Caprol, Acconon, Sterotex, Nutri Sperse, Hydro-Kote and Pureco. The range is produced in ISO-certified facilities in accordance with cGMP and IPEC guidelines. Their application areas vary from pharmaceutical, nutritional and cosmetic products, to the manufacturing of a wide choice of liquids, semi-solids, solids and powders.
About ABITEC Corporation
ABITEC Corporation is part of ABF Ingredients and is headquartered in Columbus, Ohio, US with two manufacturing sites in the Midwest. ABITEC specializes in the development and distribution of specialty lipid ingredients for use in the pharmaceutical, nutraceutical, and specialty chemical markets. In addition, ABITEC offers contract and toll manufacturing services for customers looking to develop and manufacture new oleochemical molecules, blend, or toll-manufacture an established product.
About ABF Ingredients
ABF Ingredients is a division of Associated British Foods that focuses on high value ingredients for both food and non-food areas and comprises a range of ingredient companies which include AB Enzymes, Ohly, PGP International, and SPI Pharma. The group has established strong market positions in cereal specialties, enzymes, esters, extruded ingredients, specialty lipids, specialty powders, specialty flours, yeast extracts worldwide.
About DKSH
At DKSH, our purpose is to enrich people’s lives. For more than 150 years, we have been delivering growth for companies in Asia and beyond across our Business Units Healthcare, Consumer Goods, Performance Materials and Technology. As a leading Market Expansion Services provider, we offer sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 32,450 specialists, generating net sales of CHF 10.7 billion in 2020. The DKSH Business Unit Performance Materials distributes specialty chemicals and ingredients for food, pharmaceutical, personal care and various industrial applications. With 48 innovation centers and regulatory support worldwide, we create cutting-edge formulations that comply with local regulations. With around 1,260 specialists, the Business Unit generated net sales of CHF 1.1 billion in 2020. www.dksh.com/pm
For further information, please contact:
ABITEC
Amanda Coulter
Manager: Marketing Research and Communications
614-429-6453 | [email protected]
www.abiteccorp.com
DKSH
DKSH Performance Materials
Daniel Hollister
Senior Manager, Group Marketing
Phone +44 20 8879 5500
[email protected]
Forward-Looking Statements
This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond our control. We caution you that the forward-looking information presented in this press release is not a guarantee of future events, and that actual events may differ materially from those made in or suggested by the forward-looking information contained in this press release. In addition, forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "plan," "seek," "comfortable with," "will," "expect," "intend," "estimate," "anticipate," "believe" or "continue" or the negative thereof or variations thereon or similar terminology. Any forward-looking information presented herein is made only as of the date of this press release, and we do not undertake any obligation to update or revise any forward-looking information to reflect changes in assumptions, the occurrence of unanticipated events, or otherwise.